Inge van Loo
Impact in
- Clinical Biochemistry top 2%
- Bacterial Identification and Susceptibility Testing
- Infectious Diseases top 5%
- Antimicrobial Resistance in Staphylococcus
Papers in
-
- Bacterial Identification and Susceptibility Testing 3
-
- Antimicrobial Resistance in Staphylococcus 3
- Viral gastroenteritis research and epidemiology 1
- Co-authors
- Jan A. J. W. Kluytmans (3 shared papers)Xander W. Huijsdens (3 shared papers)D. Beaujean (1 shared paper)Andreas Voß (1 shared paper)Nienke van de Sande-Bruinsma (1 shared paper)Edine W. Tiemersma (1 shared paper)Albert J. de Neeling (1 shared paper)Janusz M. Ślusarczyk (1 shared paper)
- Journals
- Vaccine (2 papers)Emerging infectious diseases (2 papers)Journal of Clinical Microbiology (1 paper)The Journal of Infectious Diseases (1 paper)Medical Research Archives (1 paper)
- Partner nations
- NetherlandsFrancePoland
In The Last Decade
Inge van Loo
9 papers receiving 496 citations
Peers
Comparison fields: 5 of 53
- Clinical Biochemistry 168
- Infectious Diseases 360
- Microbiology 81
- Applied Microbiology and Biotechnology 13
- Molecular Medicine 33
Countries citing papers authored by Inge van Loo
This map shows the geographic impact of Inge van Loo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge van Loo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge van Loo more than expected).
Fields of papers citing papers by Inge van Loo
This network shows the impact of papers produced by Inge van Loo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge van Loo. The network helps show where Inge van Loo may publish in the future.
Co-authors
The 23 scholars most cited alongside Inge van Loo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 384 | |
| 2 | 2001 | 62 | |
| 3 | 2005 | 48 | |
| 4 | 2025 | 13 | |
| 5 | 2022 | 8 | |
| 6 | 2022 | 2 | |
| 7 | 2009 | 1 | |
| 8 | Adenovirus Infection in Immunocompetent Children: Not Always as Innocent as Assumed | 2016 | 1 |
| 9 | School Closure to Reduce Infl uenza Transmission | 2009 | 1 |
About Inge van Loo
Inge van Loo is a scholar working on Clinical Biochemistry, Infectious Diseases, Microbiology, Epidemiology and Molecular Biology, having authored 9 papers that have together received 520 indexed citations. Recurring topics across this work include Bacterial biofilms and quorum sensing (3 papers), Bacterial Identification and Susceptibility Testing (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers), Viral gastroenteritis research and epidemiology (1 paper), Infective Endocarditis Diagnosis and Management (1 paper), Water Systems and Optimization (1 paper), Virus-based gene therapy research (1 paper) and Orthopedic Infections and Treatments (1 paper). The work is most often cited by research in Clinical Biochemistry (168 citations), Infectious Diseases (360 citations), Microbiology (81 citations), Applied Microbiology and Biotechnology (13 citations) and Molecular Medicine (33 citations). Inge van Loo has collaborated with scholars based in Netherlands, France and Poland. Frequent co-authors include Jan A. J. W. Kluytmans, Xander W. Huijsdens, D. Beaujean, Andreas Voß, Nienke van de Sande-Bruinsma, Edine W. Tiemersma, Albert J. de Neeling, Janusz M. Ślusarczyk, Ewa Augustynowicz and Wim Wannet. Their work appears in journals such as Vaccine, Emerging infectious diseases, Journal of Clinical Microbiology, The Journal of Infectious Diseases and Medical Research Archives.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.